---
title: "Alprostadil - Congenital atresia of tricuspid valve"
sidebar: mydoc_sidebar
permalink: db00770-mesh-d018785-1.html
toc: false 
---


Path ID: `DB00770_MESH_D018785_1`
{% include image.html url="images/db00770-mesh-d018785-1.png" file="db00770-mesh-d018785-1.png" alt="db00770-mesh-d018785-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000527 | Alprostadil | Drug |
| UniProt:P43116 | Prostaglandin E2 receptor EP2 subtype | Protein |
| GO:0007189 | Adenylate cyclase-activating G protein-coupled receptor signaling pathway | BiologicalProcess |
| GO:0044557 | Relaxation of smooth muscle | BiologicalProcess |
| HP:0001643 | Patent ductus arteriosus | PhenotypicFeature |
| MESH:D018785 | Congenital atresia of tricuspid valve | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Alprostadil | INCREASES ACTIVITY OF | Prostaglandin E2 Receptor Ep2 Subtype |
| Prostaglandin E2 Receptor Ep2 Subtype | POSITIVELY REGULATES | Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway |
| Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway | POSITIVELY REGULATES | Relaxation Of Smooth Muscle |
| Relaxation Of Smooth Muscle | POSITIVELY CORRELATED WITH | Patent Ductus Arteriosus |
| Patent Ductus Arteriosus | NEGATIVELY CORRELATED WITH | Congenital Atresia Of Tricuspid Valve |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00770#mechanism-of-action](https://go.drugbank.com/drugs/DB00770#mechanism-of-action){:target="_blank"}